Prigen Srl

Prigen Srl

Operating office:  Viale Ortles, 22/4 – 20139 Milano (MI)

Tel: +39 02 56660111

Email: info@prigen.it

Website: https://genhyalskincare.com/

Prigen is an MSME that carries out research and development of pharmaceutical, biopharmaceutical and dermo-cosmetic products. The company also performs biotechnology consulting activities related to technology transfer and offers contract R & D services.

Prigen’s research and development activities are carried out both internally, operating with qualified internal personnel and/or through the support of the founding partners, or with external resources activated through agreements or contracts with external research groups (University, CNR, service companies ). Prigen has 2 operational offices: in the Campania Region in Naples and in the Lombardy Region in Milan.

Research and development activities are applied to the following topics:

  • Controlled-release drug formulations: An important area of ​​activity is dedicated to the preparation of innovative pharmaceutical formulations and the reformulation of drugs already on the market, with the aim of improving compliance, reducing side effects and optimizing their use therapeutic. Prigen is able to apply various technologies to develop new formulations that can be used for parenteral and topical administrations. Prigen has a patent on Glycerosomal technology (WO 2010/102770), capable of increasing the performance of drugs or cosmetic products with topical formulations.
  • Cosmetics: Prigen’s activities in this sector also focus on biotechnological studies aimed at the identification and purification of active ingredients derived from endemic plants of Sardinia, useful for the preparation of innovative topical formulations for the treatment of dermatological pathologies. Prigen is also engaged in the research and selection of products based on waste from the agri-food chain as ingredients for the formulation of its low environmental impact cosmetics.
  • Technical and scientific activities in Dermocosmetics: Research and development of formulations containing Glycerosomal technology and innovative biomaterials for the production of serums, creams, gels, tonics, etc.)

Prigen’s dermocosmetic line embodies and realizes the concept of innovative formula, technology and essentiality, in accordance with a real corporate mission in the topical formulation sector:

  • Essentiality
  • Effectiveness
  • Eco-sustainability of ingredients
  • Quality & Safety
  • Technology and Innovation.